ISSUED ON BEHALF OF RELX PLC
Result of Annual General Meeting 2022
The Company held its Annual General Meeting ("AGM") at 09:30am today, Thursday 21 April 2022.
All valid proxy votes (whether submitted electronically or in hard copy form) were included in the poll taken at the meeting.
The table below shows the results of the poll on all 20 resolutions.
|
|
Resolution |
For |
% votes cast For |
Against |
% votes cast Against |
Total votes cast (excluding votes withheld) |
% of issued capital voted (excluding Treasury shares) |
Withheld |
|
1. |
Receive the 2021 Annual Report |
1,491,275,770 |
99.78 |
3,335,597 |
0.22 |
1,494,611,367 |
77.45% |
2,126,644 |
|
2. |
Approve Annual Remuneration Report |
1,373,261,824 |
91.85 |
121,919,012 |
8.15 |
1,495,180,836 |
77.48% |
1,557,175 |
|
3. |
Declaration of 2021 Final Dividend |
1,493,177,822 |
99.77 |
3,425,530 |
0.23 |
1,496,603,352 |
77.56% |
134,659 |
|
4. |
Re-appointment of auditors |
1,485,348,662 |
99.26 |
11,062,875 |
0.74 |
1,496,411,537 |
77.55% |
326,474 |
|
5. |
Auditors' remuneration |
1,493,500,529 |
99.81 |
2,876,603 |
0.19 |
1,496,377,132 |
77.55% |
360,879 |
|
6. |
Re-elect Paul Walker as a Director |
1,467,667,180 |
98.07 |
28,845,485 |
1.93 |
1,496,512,665 |
77.55% |
225,346 |
|
7. |
Re-elect June Felix as a Director |
1,494,824,919 |
99.89 |
1,589,342 |
0.11 |
1,496,414,261 |
77.55% |
323,750 |
|
8. |
Re-elect Erik Engstrom as a Director |
1,494,726,200 |
99.88 |
1,778,075 |
0.12 |
1,496,504,275 |
77.55% |
233,736 |
|
9. |
Re-elect Wolfhart Hauser as a Director |
1,440,131,331 |
97.78 |
32,721,119 |
2.22 |
1,472,852,450 |
76.33% |
23,885,561 |
|
10. |
Re-elect Charlotte Hogg as a Director |
1,495,251,731 |
99.92 |
1,159,739 |
0.08 |
1,496,411,470 |
77.55% |
326,541 |
|
11. |
Re-elect Marike van Lier Lels as a Director |
1,476,195,582 |
98.65 |
20,215,292 |
1.35 |
1,496,410,874 |
77.55% |
327,137 |
|
12. |
Re-elect Nick Luff as a Director |
1,488,575,157 |
99.47 |
7,933,794 |
0.53 |
1,496,508,951 |
77.55% |
229,060 |
|
13. |
Re-elect Robert MacLeod as a Director |
1,466,439,977 |
98.53 |
21,818,670 |
1.47 |
1,488,258,647 |
77.12% |
8,479,364 |
|
14. |
Re-elect Andrew Sukawaty as a Director |
1,494,740,397 |
99.89 |
1,660,132 |
0.11 |
1,496,400,529 |
77.55% |
337,482 |
|
15. |
Re-elect Suzanne Wood as a Director |
1,411,122,951 |
94.30 |
85,291,485 |
5.70 |
1,496,414,436 |
77.55% |
323,575 |
|
16. |
Authority to allot shares |
1,426,795,249 |
95.33 |
69,832,233 |
4.67 |
1,496,627,482 |
77.56% |
110,529 |
|
17. |
Disapplication of pre-emption rights |
1,485,969,136 |
99.54 |
6,889,235 |
0.46 |
1,492,858,371 |
77.36% |
3,879,640 |
|
18. |
Additional disapplication of pre-emption rights |
1,464,529,391 |
98.10 |
28,326,287 |
1.90 |
1,492,855,678 |
77.36% |
3,882,333 |
|
19. |
Authority to purchase own shares |
1,476,765,192 |
98.75 |
18,663,830 |
1.25 |
1,495,429,022 |
77.50% |
1,308,989 |
|
20. |
Notice period for general meetings |
1,406,037,769 |
94.13 |
87,690,996 |
5.87 |
1,493,728,765 |
77.41% |
3,009,246 |
NOTES:
1. The 'For' vote includes those giving the Chair discretion.
2. Votes 'Withheld' are not counted in the calculation of the proportion of votes 'For' or 'Against' a resolution.
3. Resolutions 17 to 20 are Special Resolutions.
4. At the close of business on Tuesday 19 April 2022 the total number of ordinary shares in issue, excluding Treasury shares, was 1,929,677,490.
5. The full text of the resolutions can be found in the Notice of Annual General Meeting, which is available for inspection at the National Storage Mechanism https://data.fca.org.uk/#/nsm/nationalstoragemechanism and on the Company's website at www.relx.com.
6. As per Listing Rule 9.6.2 a copy of the resolutions passed, other than resolutions concerning ordinary business, will shortly be submitted to the National Storage Mechanism for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
